Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.
Despite high coverage with pertussis-containing vaccines, pertussis remains endemic to the United States. There have been increases in reported cases in recent years, punctuated by striking epidemics and shifting epidemiology, both of which raise questions about current policies regarding its prevention and control. Limited data on pertussis reported through the National Notifiable Disease Surveillance System have proved insufficient to answer these questions. To address shortcomings of national pertussis data, the Emerging Infections Program at the US Centers for Disease Control and Prevention launched Enhanced Pertussis Surveillance (EPS), which is characterized by systematic case ascertainment, augmented data collection, and collection of Bordetella pertussis isolates. Data collected through EPS have been instrumental in understanding the rapidly evolving epidemiology and molecular epidemiology of pertussis and have contributed essential information regarding pertussis vaccines. EPS also serves as a platform for conducting critical and timely evaluations of pertussis prevention and control strategies, including targeting of vaccinations and antimicrobial prophylaxis.
Tami H
TH
Skoff
Joan
J
Baumbach
Paul R
PR
Cieslak
D001886:Bordetella pertussis / Q000276:immunology; D003140:Communicable Disease Control / Q000592:standards*; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D017063:Outcome Assessment, Health Care; D010567:Pertussis Vaccine; D062486:Public Health Surveillance; D014481:United States / Q000453:epidemiology; D014611:Vaccination; D014917:Whooping Cough / Q000453:epidemiology* / Q000517:prevention & control
D010567:Pertussis Vaccine
Bordetella pertussis; EIP; Emerging Infections Program; Enhanced Pertussis Surveillance; National Notifiable Disease Surveillance System; bacteria; pertussis; preventable bacterial disease; surveillance; vaccine; whooping cough